|
Proton pump inhibitor approved as first 7-day treatment of H. pylori.
Publication: Drug Week Publication Date: 27-DEC-02 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2002 NewsRX
2002 DEC 27 - (NewsRx.com & NewsRx.net) -- Aciphex, a proton pump inhibitor (PPI) widely prescribed for gastroesophageal reflux disease (GERD), is now approved by the Food and Drug Administration as part of the first 7-day treatment for Helicobacter pylori infection, the single most common cause of peptic ulcers.
Taken in combination with certain antibiotics, Aciphex offers a faster therapy option than other PPIs, treating H. pylori in...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Drug Week |
FDA committee recommends approval of Pegasys with Copegus.
December 27, 2002
|
Eximias, LG Life Sciences collaborate to market Thymitaq in Korea.
December 27, 2002
|
Biomatrix assay useful for testing therapeutic agents.
December 27, 2002
|
Epstein-Barr virus latent membrane protein can be therapeutic target.
December 27, 2002
|
Enrollment completed for BLP25 liposomal vaccine.
December 27, 2002
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
